Since the early demonstrations of cross-species microsatellite amplification in birds (e.g. [ 20], attempts have been made to identify a useful number of primer sets of high utility in a wide range of avian species.
Juergen Maier, CEO of Siemens, which started building on a £310m wind turbine factory in Hull in January, said: "The low-carbon transition represents a major economic opportunity and this demonstration of cross-party support sends a clear message that the UK remains a good place for global companies to do low-carbon business".
For these instruments to be useful in clinical research, they must undergo a proper psychometric validation, including demonstration of cross-sectional and longitudinal measurement properties.
Successful demonstration of cross-modal second-order conditioning indicates that OA/DA-ergic neurons that convey reward/punishment signals in olfactory learning can also convey reward/punishment signals in visual learning.
Although much indirect or in vitro evidence supports the importance of α2AP cross-linking to fibrin with respect to clot resistance to fibrinolysis [ 22, 23, 39, 40], this is to our knowledge the first demonstration of cross-linking of either α2AP protein or an engineered polypeptide into in vivo thrombi.
The demonstration of cross-talk between drugs and lipids on CAR implies that there will be drug lipid interactions associated with effects on this receptor and evidence for this is provided by the work of Li et al. [ 55], who showed that PUFAs could influence the induction of P450 genes by PB.
This, together with the demonstration of cross-talk between TGFβ signalling and Notch signalling (Blokzijl et al., 2003; Larrivée et al., 2012; Zavadil et al., 2004), raised the possibility that GDF5 might exert its effects on dendrite growth by upregulating the expression of these transcription factors.
The demonstration of cross-informant variance and the general acceptance that HRQOL derives from an individual's perceptions [ 17], indicates an essential need in pediatric HRQOL measurement for reliable and valid child self-report instruments for the broadest age range possible.
The demonstration of cross-informant variance and the general acceptance that HRQOL and symptoms derive from an individual's perceptions [ 5], indicates an essential need in pediatric symptom measurement for reliable and valid pediatric patient self-report instruments for the broadest age range possible.
Open image in new window Fig. 1 Demonstration of a cross-docking network.
- The first demonstration of vaccine cross-protection in the setting of a clinical trial was in 1985.
